| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88383e74cd125aa2e8603b07c6d09019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19f54e9050dd87ae74606d2beb34fe07 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
| filingDate |
1993-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79cdf44414d49ce7c0d558f597e8c945 |
| publicationDate |
1994-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9402138-A1 |
| titleOfInvention |
Pharmaceutical composition and method of treatment for serotonin depletion illness |
| abstract |
This invention relates to the treatment of a condition characterized as serotonin depletion illness (SDI) with compositions and methods comprising a serotonin agonist in combination with sulpiride. SDI is an illness which may be commonly identified by fatigue, irritability, sleep disorders and pain in afflicted patients. Preferred serotonin agonists for use in the treatment of SDI are tricyclic antidepressants, maprotiline and mianserin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9843646-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6596759-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6413961-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6261279-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6056715-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-298105-B6
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6242447-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6150353-A |
| priorityDate |
1992-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |